TrialJournal of thrombosis and haemostasis : JTH2021

First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa.

Dirk Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.